ARCHIVES

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

“Dog And Pony Show” At FCRF For NCAB OFF

April 25, 1980

NCI Faced Pressure From Congress, HHS, White On Mammography Statement

April 11, 1997

NIH Responds To IOM Report On Women’s Health Initiative

November 12, 1993

Columbia Receives $1 Million ACS Grants

May 3, 1985

Groups Have No Budgets As NCTN Begins Work March 1

February 28, 2014

Intramural Funding To Decrease, R01s Increase, Klausner Says

September 15, 1995